Discover our findings and learn more about our trials.
See our pipeline for work planned and in progress
Discover our findings and learn more about our trials.
Human Clinical Trials
2024/10
2024/10
Osteo duo:
HUMAN CLINICAL TRIAL PUBLISHED
Osteo duo:
HUMAN CLINICAL TRIAL PUBLISHED
The Effect of Lacticaseibacillus paracasei LPC100 and Lactiplantibacillus plantarum LP140 on Bone Mineral Density in Postmenopausal Women: A Multicenter, Randomized, Placebo-Controlled Study
2024/01
2024/01
IMMUNOVIR:
HUMAN CLINICAL TRIAL PUBLISHED
IMMUNOVIR:
HUMAN CLINICAL TRIAL PUBLISHED
The role of nutritional support with probiotics in outpatients with symptomatic acute respiratory tract infections: a multicenter, randomized, double‑blind, placebo‑controlled dietary study.
2023/07
2023/07
GASTRO ONE BC300:
HUMAN CLINICAL TRIAL PUBLISHED
GASTRO ONE BC300:
HUMAN CLINICAL TRIAL PUBLISHED
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
2023/07
2023/07
GASTRO ONE BI040:
HUMAN CLINICAL TRIAL PUBLISHED
GASTRO ONE BI040:
HUMAN CLINICAL TRIAL PUBLISHED
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
2021/02
2021/02
GASTRO IBS-10:
HUMAN CLINICAL TRIAL PUBLISHED
GASTRO IBS-10:
HUMAN CLINICAL TRIAL PUBLISHED
The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
In-vitro and significant findings
2024/11
2024/11
NORDBIOTIC™ LU150:
COMPLETE GENOME SEQUENCE
Complete genome sequence of Limosilactobacillus reuteri LU150, a potential vitamin B12 producer from the NORDBIOTIC collection.
2024/11
2024/11
NORDBIOTIC™ LP140:
COMPLETE GENOME SEQUENCE
NORDBIOTIC™ LP140:
COMPLETE GENOME SEQUENCE
Complete genome sequence of a potentially probiotic cheese isolate Lactiplantibacillus plantarum LP140 from the NORDBIOTIC collection.
2024/08
2024/08
NORDBIOTIC™ LC130:
COMPLETE GENOME SEQUENCE
NORDBIOTIC™ LC130:
COMPLETE GENOME SEQUENCE
Whole-genome sequencing and characterization of human fecal isolate Lacticaseibacillus casei LC130 from NORDBIOTIC collection.
2024/02
2024/02
NORDBIOTIC™ LPC100:
COMPLETE GENOME SEQUENCE
NORDBIOTIC™ LPC100:
COMPLETE GENOME SEQUENCE
Complete genome sequence of the probiotic Lacticaseibacillus paracasei LPC100 strain from NORDBIOTIC™ collection isolated from a human fecal sample.
2024/01
2024/01
NORDBIOTIC™ strain:
MIXTURE FOR GLUTEN DIGESTION
NORDBIOTIC™ strain:
MIXTURE FOR GLUTEN DIGESTION
Lacticaseibacillus casei LC130 strain, Lacticaseibacillus paracasei LPC100 strain, Streptococcus salivarius ssp. thermophilus ST250 strain – composition reducing the immunoreactivity of gliadin peptides and the use of strains for the production of the composition. Polish patent application no. P.447563
2023/10
2023/10
SCIENTIFIC RATIONAL OF STRAIN SELECTION FOR CHILDREN’S HEATH
SCIENTIFIC RATIONAL OF STRAIN SELECTION FOR CHILDREN’S HEATH
The effectiveness of selected Lactobacillus and Bifidobacterium strains for support the holistic health and well-being of children.
2023/05
2023/05
NORDBIOTIC™ BABY:
SCIENTIFIC RATIONAL OF STRAIN SELECTION
NORDBIOTIC™ BABY:
SCIENTIFIC RATIONAL OF STRAIN SELECTION
The effectiveness of selected lactobacillus and Bifidobacterium on infantile colic.
2023/05
2023/05
CLINICAL RATIONAL – NORDBIOTIC™ 5 STRAIN COMBINATION
CLINICAL RATIONAL – NORDBIOTIC™ 5 STRAIN COMBINATION
The effectiveness of selected Lactobacillus and Bifidobacterium lactis BI040 strains for support the health.
2023/05
2023/05
FEMAX:
ENHANCING IRON ABSORPTION
FEMAX:
ENHANCING IRON ABSORPTION
Development of a Multilayer Probiotic Tablet for Enhanced Iron Absorption: Harnessing the Potential of NORDBIOTIC™ LC130, LPC100.
2022/11
2022/11
RESISTANCE OF NORDBIOTIC™ STRAINS TO SELEN
RESISTANCE OF NORDBIOTIC™ STRAINS TO SELEN
Selection of NORDBIOTIC™ strains resistant to selenomethionine.
2022/10
2022/10
TARGET SHIELD NORDBIOTIC™:
PROTECTION OF MICROBIOME
TARGET SHIELD NORDBIOTIC™:
PROTECTION OF MICROBIOME
Development of specific NORDBIOTIC™ composition of strains for antibiotic therapy.